D. Denning, A. Pleuvry, and D. Cole, Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults, Medical Mycology, vol.140, issue.4, pp.361-370, 2013.
DOI : 10.1093/cid/cir179

URL : https://academic.oup.com/mmy/article-pdf/51/4/361/3407031/51-4-361.pdf

D. Denning, A. Pleuvry, and D. Cole, Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis, Bulletin of the World Health Organization, vol.89, issue.12, pp.864-872, 2011.
DOI : 10.2471/BLT.11.089441

URL : http://doi.org/10.2471/blt.11.089441

D. Denning, A. Pleuvry, and D. Cole, Global burden of chronic pulmonary aspergillosis complicating sarcoidosis, European Respiratory Journal, vol.41, issue.3, pp.621-626, 2013.
DOI : 10.1183/09031936.00226911

URL : http://erj.ersjournals.com/content/erj/41/3/621.full.pdf

G. Brown, D. Denning, N. Gow, S. Levitz, M. Netea et al., Hidden Killers: Human Fungal Infections, Science Translational Medicine, vol.14, issue.2, pp.165-113, 2012.
DOI : 10.1258/0956462981922728

T. Walsh, E. Anaissie, D. Denning, R. Herbrecht, D. Kontoyiannis et al., Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.21, issue.3, pp.327-360, 2008.
DOI : 10.1086/313938

M. Levin, J. Hollander, B. Van-der-holt, B. Rijnders, M. Van-vliet et al., Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms, Journal of Antimicrobial Chemotherapy, vol.60, issue.5, pp.1104-1107, 2007.
DOI : 10.1093/jac/dkm330

URL : https://academic.oup.com/jac/article-pdf/60/5/1104/6959211/dkm330.pdf

A. Lat, G. Thompson, and I. , Update on the optimal use of voriconazole for invasive fungal infections, Infect Drug Resist, vol.4, pp.43-53, 2011.

D. Wexler, R. Courtney, W. Richards, C. Banfield, J. Lim et al., Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study, European Journal of Pharmaceutical Sciences, vol.21, issue.5, pp.645-653, 2004.
DOI : 10.1016/j.ejps.2004.01.005

S. Jeong, P. Nguyen, and Z. Desta, Comprehensive In Vitro Analysis of Voriconazole Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effect on CYPs 2B6, 2C9, 2C19, and 3A, Antimicrobial Agents and Chemotherapy, vol.53, issue.2, pp.541-551, 2009.
DOI : 10.1128/AAC.01123-08

T. Colley, K. Ito, G. Rapeport, P. Strong, P. Murray et al., Antimycotic compound, 2016.

R. Copeland, Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists, Methods Biochem Anal, vol.46, pp.1-265, 2005.
DOI : 10.1002/9781118540398

URL : http://doi.org/10.1002/9781118540398

D. Denning, K. Venkateswarlu, K. Oakley, M. Anderson, N. Manning et al., Itraconazole resistance in Aspergillus fumigatus, Antimicrob Agents Chemother, vol.41, pp.1364-1368, 1997.

G. Atherton, posting date Aspergillus fumigatus isolate AF293 (NCPF 7367), 2014.

E. , Antifungal agent breakpoint tables for interpretation of MICs, 2015.

T. Diaz-guerra, E. Mellado, M. Cuenca-estrella, and J. Rodriguez-tudela, A Point Mutation in the 14??-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus, Antimicrobial Agents and Chemotherapy, vol.47, issue.3, pp.1120-1124, 2003.
DOI : 10.1128/AAC.47.3.1120-1124.2003

S. Rocchi, E. Daguindau, F. Grenouillet, E. Deconinck, A. Bellanger et al., Azole-Resistant Aspergillus fumigatus Isolate with the TR34/L98H Mutation in Both a Fungicide-Sprayed Field and the Lung of a Hematopoietic Stem Cell Transplant Recipient with Invasive Aspergillosis, Journal of Clinical Microbiology, vol.52, issue.5, pp.1724-172603182, 2014.
DOI : 10.1128/JCM.03182-13

URL : https://hal.archives-ouvertes.fr/hal-01063888

M. Wickham, N. Brown, J. Provias, B. Finlay, and B. Coombes, Oral infection of mice with Salmonella enterica serovar Typhimurium causes meningitis and infection of the brain, BMC Infect Dis, vol.7, pp.651471-2334, 2007.

C. Sharma, F. Hagen, R. Moroti, J. Meis, and A. Chowdhary, Triazole-resistant Aspergillus fumigatus harbouring G54 mutation: Is it de novo or environmentally acquired?, Journal of Global Antimicrobial Resistance, vol.3, issue.2, pp.69-74, 2015.
DOI : 10.1016/j.jgar.2015.01.005

S. Howard, D. Cerar, M. Anderson, A. Albarrag, M. Fisher et al., Associated with Treatment Failure1, Emerging Infectious Diseases, vol.15, issue.7, pp.1068-1076, 2009.
DOI : 10.3201/eid1507.090043

A. Bueid, S. Howard, C. Moore, M. Richardson, E. Harrison et al., Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009, Journal of Antimicrobial Chemotherapy, vol.51, issue.6, pp.2116-2118, 2010.
DOI : 10.1128/AAC.01092-06

S. Wong, R. Kao, K. Yuen, Y. Wang, D. Yang et al., In Vitro and In Vivo Activity of a Novel Antifungal Small Molecule against Candida Infections, PLoS ONE, vol.19, issue.1, 2014.
DOI : 10.1371/journal.pone.0085836.s001

A. Gifford, J. Klippenstein, and M. Moore, Serum Stimulates Growth of and Proteinase Secretion by Aspergillus fumigatus, Infection and Immunity, vol.70, issue.1, pp.19-26, 2002.
DOI : 10.1128/IAI.70.1.19-26.2002

A. Rodrigues, R. Araujo, and C. Pina-vaz, Medical Mycology, vol.39, issue.16, pp.711-717, 2005.
DOI : 10.1128/JCM.39.2.478-484.2001

C. , Antibiotic resistance threats in the United States, 2013: fluconazole-resistant Candida, CDC, 2013.

B. Park, K. Wannemuehler, B. Marston, N. Govender, P. Pappas et al., Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS, AIDS, vol.23, issue.4, pp.525-530, 2009.
DOI : 10.1097/QAD.0b013e328322ffac

M. Roden, T. Zaoutis, W. Buchanan, T. Knudsen, T. Sarkisova et al., Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases, Clinical Infectious Diseases, vol.46, issue.2, pp.634-653, 2005.
DOI : 10.2214/ajr.144.6.1195

C. Jefcoate, J. Gaylor, and R. Calabrese, Ligand interactions with cytochrome P-450. I. Binding of primary amines, Biochemistry, vol.8, issue.8, pp.3455-3463, 1969.
DOI : 10.1021/bi00836a049

C. Jefcoate, [27] Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy, Methods Enzymol, vol.52, issue.78, pp.258-27910, 1978.
DOI : 10.1016/S0076-6879(78)52029-6

S. Kelly, D. Lamb, A. Corran, B. Baldwin, and D. Kelly, Mode of Action and Resistance to Azole Antifungals Associated with the Formation of 14??-Methylergosta-8,24(28)-dien-3??,6??-diol, Biochemical and Biophysical Research Communications, vol.207, issue.3, pp.910-915, 1995.
DOI : 10.1006/bbrc.1995.1272

B. Hoeben, D. Burgess, J. Mcconville, L. Najvar, R. Talbert et al., In Vivo Efficacy of Aerosolized Nanostructured Itraconazole Formulations for Prevention of Invasive Pulmonary Aspergillosis, Antimicrobial Agents and Chemotherapy, vol.50, issue.4, pp.1552-1554, 2006.
DOI : 10.1128/AAC.50.4.1552-1554.2006

O. Hilberg, C. Andersen, O. Henning, T. Lundby, J. Mortensen et al., Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis: Figure 1???, European Respiratory Journal, vol.40, issue.1, pp.271-273, 2012.
DOI : 10.1183/09031936.00163511

R. Drew, D. Ashley, E. Benjamin, D. Jr, D. Davis et al., Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients, Transplantation, vol.77, issue.2, pp.232-237, 2004.
DOI : 10.1097/01.TP.0000101516.08327.A9

J. Blaser, B. Stone, M. Groner, and S. Zinner, Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance., Antimicrobial Agents and Chemotherapy, vol.31, issue.7, pp.1054-1060, 1987.
DOI : 10.1128/AAC.31.7.1054

G. Drusano, Antimicrobial pharmacodynamics: critical interactions of 'bug and drug', Nature Reviews Microbiology, vol.19, issue.Suppl., pp.289-300, 2004.
DOI : 10.1016/S0924-8579(02)00031-6

A. Warrilow, N. Melo, C. Martel, J. Parker, W. Nes et al., Expression, Purification, and Characterization of Aspergillus fumigatus Sterol 14-?? Demethylase (CYP51) Isoenzymes A and B, Antimicrobial Agents and Chemotherapy, vol.54, issue.10, pp.4225-4234, 2010.
DOI : 10.1128/AAC.00316-10

J. Lutz, V. Dixit, C. Yeung, L. Dickmann, A. Zelter et al., Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylase, Biochemical Pharmacology, vol.77, issue.2, pp.258-268, 2009.
DOI : 10.1016/j.bcp.2008.10.012

A. Warrilow, J. Parker, C. Price, W. Nes, S. Kelly et al., ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.59, issue.12, pp.7771-7778, 2015.
DOI : 10.1128/AAC.01806-15

J. Parker, A. Warrilow, H. Cools, B. Fraaije, J. Lucas et al., ABSTRACT, Applied and Environmental Microbiology, vol.79, issue.5, pp.1639-164503246, 2013.
DOI : 10.1128/AEM.03246-12

M. Arendrup, J. Guinea, M. Cuenca-estrella, J. Meletiadis, J. Mouton et al., EUCAST definitive document EDef 9.3. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds, 2015.

M. Arendrup, M. Cuenca-estrella, C. Lass-florl, and W. Hope, EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*, Clinical Microbiology and Infection, vol.18, issue.7, pp.246-247, 2012.
DOI : 10.1111/j.1469-0691.2012.03880.x

M. Arendrup, M. Cuenca-estrella, C. Lass-flörl, W. Hope, and S. Howard, EUCAST definitive document EDef 9.2. Method for the determination of broth microdilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds, 2014.

, Document M38-A. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, 2008.

, Antifungal Activity of Novel Azole PC945 Antimicrobial Agents and Chemotherapy Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard

A. Zaas, G. Liao, J. Chien, C. Weinberg, D. Shore et al., Plasminogen Alleles Influence Susceptibility to Invasive Aspergillosis, PLoS Genetics, vol.11, issue.6, 2008.
DOI : 10.1371/journal.pgen.1000101.s004

S. Herbst, A. Shah, M. Carby, G. Chusney, N. Kikkeri et al., A new and clinically relevant murine model of solid-organ transplant aspergillosis, Disease Models & Mechanisms, vol.6, issue.3, pp.643-651, 2013.
DOI : 10.1242/dmm.010330

D. Southam, M. Dolovich, O. Byrne, P. Inman, and M. , Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia, American Journal of Physiology-Lung Cellular and Molecular Physiology, vol.90, issue.4, pp.833-839, 2001.
DOI : 10.1164/ajrccm.155.2.9032210

. Colley, Antimicrobial Agents and Chemotherapy